Cited by 702Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Health and Risk Factors

The DOI matches its Crossref record; 87 of the 88 references it cites were found in a registry or an index.

Epidemiology as a Guide to Clinical Decisions: The Association between Triglyceride and Coronary Heart Disease

Hulley, Stephen B., Rosenman, Ray H., Bawol, Richard D., Brand, Richard J.·1980·New England Journal of Medicine

DOI 10.1056/nejm198006193022503

Open this paper in CoChat — free account

Abstract

The hypothesis that triglyceride is a cause of coronary heart disease, although unconfirmed and never universally accepted, has nonetheless strongly influenced the practice of preventive medicine. We have examined the epidemiologic association between triglyceride and coronary heart disease to evaluate the validity of inferring that there is a causal relation between the two. Neither the evidence from published studies nor an analysis of data from the Western Collaborative Group Study provides strong support for the causal hypothesis. Information from other scientific disciplines is also meager, contrasting with the coherence of diverse evidence supporting the hypothesis that cholesterol is a cause of coronary heart disease. These arguments fall short of disproving the belief that lowering triglyceride will prevent coronary heart disease, especially since triglyceride and cholesterol are inextricably associated through mutual lipoprotein carriers. But we propose that the ethics of preventive medicine place the burden of proof on the proponents of intervention. We therefore recommend that widespread screening and treatment of healthy persons for hypertriglyceridemia be abandoned until more persuasive evidence becomes available.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm198006193022503

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.
Kannel, W., Castelli, W., Gordon, T., & McNamara, P. M. (2020) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,160
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,911
Clofibrate and Niacin in Coronary Heart Disease
Stamler, J. (1975) · JAMA · doi:10.1001/jama.1975.03240160024021 · Cited by 1,750
HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study
Castelli, W. P., Doyle, J. T., Gordon, T., Hames, C. G., Hjortland, M. C., Hulley, S. B., Kagan, A., & Zukel, W. J. (1977) · Circulation · doi:10.1161/01.cir.55.5.767 · Cited by 1,492
Self-citation
Cholesterol in the Prediction of Atherosclerotic Disease
Kannel, W. B., Castelli, W. P., & Gordon, T. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-1-85 · Cited by 1,314
Coronary Heart Disease in the Western Collaborative Group Study
Rosenman, R. H. (1975) · JAMA · doi:10.1001/jama.233.8.872 · Cited by 1,274
Self-citation
A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.
Oliver, M., Heady, J., Morris, J. N., Cooper, J., Geizerova, H., Gyárfás, I., Green, K., Strasser, T., Macfie, W. G., Scott, E., et al. (1978) · Heart · doi:10.1136/hrt.40.10.1069 · Cited by 1,047
Effect of Weight Loss without Salt Restriction on the Reduction of Blood Pressure in Overweight Hypertensive Patients
Reisin, E., Abel, R., Modan, M., Silverberg, D. S., Eliahou, H. E., & Modan, B. (1978) · New England Journal of Medicine · doi:10.1056/nejm197801052980101 · Cited by 759
ISCHÆMIC HEART-DISEASE IN RELATION TO FASTING VALUES OF PLASMA TRIGLYCERIDES AND CHOLESTEROL
Carlson, L., & Böttiger, L. E. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90738-6 · Cited by 752
Hyperlipidemia in Coronary Heart Disease I. LIPID LEVELS IN 500 SURVIVORS OF MYOCARDIAL INFARCTION
Goldstein, J. L., Hazzard, W. R., Schrott, H. G., Bierman, E. L., & Motulsky, A. G. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107331 · Cited by 621

Show all 88 references

Research works printed but not linked: 11

Hayes, 1964, Clin Sci, 26, 185
Rhoads, 1978, Lab Invest, 38, 304
Bierman EL. Atherosclerosis and other forms of arteriosclerosis. In: Isselbacher KJ, Adams RD, Braunwald E, Petersdorf RG, Wilson JD, eds. Harrison's principles of internal medicine. 9th edition. New York: McGraw-Hill, 1980:1156–66.
Cornfield, 1959, Am J Ment Defic, 64, 240
Grundy, 1978, West J Med, 128, 13
McGill HC. Atherosclerosis: problems in pathogenesis. In: Paoletti R, Gotto AM, eds. Atherosclerosis Reviews. Vol. 2. New York: Raven Press, 1977; 2:27–65.
Vil, 1978, N Engl J Med, 298, 109
10.1001/jama.231.4.360 · DOI
McKeown T. Unvalidated procedures have no place in screening programs. In: Ingelfinger FJ, Ebert RV, Finland M, Relman AS, eds. Controversies in internal medicine II. Philadelphia: WB Saunders, 1974:92–8.
University Group Diabetes Program, 1970, Diabetes, 19, 785
University Group Diabetes Program, 1975, Diabetes, 24, 65

Sorted by citations

Items 201–300 of 701

Etretinate Therapy Causes Increases in Lipid Levels in Patients With Psoriasis
Ellis, C. N. (1982) · Archives of Dermatology · doi:10.1001/archderm.1982.01650200027010 · Cited by 55
ApoCIII as a cardiovascular risk factor and modulation by the novel lipid-lowering agent volanesorsen
Rocha, N. A., East, C., Zhang, J., & McCullough, P. A. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0697-3 · Cited by 54
Pathogenesis of hyperlipoproteinemia
Grundy, S. M. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34439-4 · Cited by 54
Hypertension, hyperlipoproteinemia, chronic noise exposure: Is there synergism in cochlear pathology?
Pillsbury, H. C. (1986) · The Laryngoscope · doi:10.1288/00005537-198610000-00012 · Cited by 53
The Critical Aggregation Concentration of β-Lactoglobulin-Based Fibril Formation
Kroes-Nijboer, A., Venema, P., Bouman, J., & van der Linden, E. (2009) · Food Biophysics · doi:10.1007/s11483-009-9101-3 · Cited by 52
The association between circulating white blood cell count, triglyceride level and cardiovascular and all-cause mortality: Population-based cohort study
Shankar, A., Mitchell, P., Rochtchina, E., & Wang, J. J. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.04.029 · Cited by 52
Interrelationship of plasma triglyceride and coagulant factor VII levels in normotriglyceridemic hypercholesterolemia
Bruckert, É., Sousa, J., Giral, P., Soria, C., Chapman, M. J., Caen, J., & de Gennes, J.-L. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90169-x · Cited by 52
Risk factors for premature death in middle aged men
Petersson, B., Trell, E., Henningsen, N. C., & HOOD, B. (1984) · BMJ · doi:10.1136/bmj.288.6426.1264 · Cited by 51
A brief review paper of the efficacy and safety of atorvastatin in early clinical trials.
Bakker-Arkema, R., Best, J. D., Fayyad, R., Heinonen, T., Marais, A., Nawrocki, J., & Black, D. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)06066-8 · Cited by 45
The epidemiology of triglyceride as a coronary artery disease risk factor
Miller, M. J. (1999) · Clinical Cardiology · doi:10.1002/clc.4960221402 · Cited by 51
Common Polymorphism in Promoter of Microsomal Triglyceride Transfer Protein Gene Influences Cholesterol, ApoB, and Triglyceride Levels in Young African American Men
Juo, S. H., Han, Z., Smith, J. D., Colangelo, L. A., & Liu, K. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.5.1316 · Cited by 51
Postchallenge plasma lipoprotein retinoids: Chylomicron remnants in endogenous hypertriglyceridemia
Wilson, D. E., Chan, I.-F., Buchi, K. N., & Horton, S. C. (1985) · Metabolism · doi:10.1016/0026-0495(85)90193-3 · Cited by 51
Fasting Serum Cholesterol and Triglycerides in a Ten‐Year Prospective Study in Old Age
Agner, E., & Hansen, P. F. (1983) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1983.tb08567.x · Cited by 51
Hypertriglyceridemia and Atherosclerosis: Using Human Research to Guide Mechanistic Studies in Animal Models
Basu, D., & Bornfeldt, K. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00504 · Cited by 51
Hypertriglyceridemia and risk of coronary heart disease
Hokanson, J. E. (2002) · Current Cardiology Reports · doi:10.1007/s11886-002-0112-7 · Cited by 50
Hyperlipidaemia due to isotretinoin and etretinate: possible mechanisms and consequences
Marsden, J. R. (1986) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1986.tb02842.x · Cited by 50
Hypertriglyceridaemia and vascular risk
Tan, K. C. B., Betteridge, D. J., Marmot, M. G., Talmud, P. J., Humphries, S. E., & Yudkin, J. S. (1993) · The Lancet · doi:10.1016/0140-6736(93)91544-v · Cited by 52
Aetiology of peripheral atherosclerosis.
Fowkes, F. G. R. (1989) · BMJ · doi:10.1136/bmj.298.6671.405 · Cited by 49
Risk of cardiovascular events in patients at optimal values for combined lipid parameters
Stanek, E. J., Sarawate, C. A., Willey, V. J., Charland, S. L., & Cziraky, M. J. (2007) · Current Medical Research and Opinion · doi:10.1185/030079906x167660 · Cited by 47
Association of plasma triglyceride and C-peptide with coronary heart disease in Japanese-American men with a high prevalence of glucose intolerance
Bergstrom, R. W., Leonetti, D. L., Newell‐Morris, L. L., Shuman, W. P., WAHL, P. W., & Fujimoto, W. Y. (1990) · Diabetologia · doi:10.1007/bf00405111 · Cited by 48
Computers, Health Care, and Medical Information Science
Lincoln, T. L., & Korpman, R. A. (1980) · Science · doi:10.1126/science.6999622 · Cited by 48
Lipids, Diabetes, and Vascular Disease: The Time to Act
Betteridge, D. J. (1989) · Diabetic Medicine · doi:10.1111/j.1464-5491.1989.tb01149.x · Cited by 48
Introduction
Assmann, G., Gotto, A. M., & Paoletti, R. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90850-k · Cited by 48
Mortality risk of triglyceride levels in patients with coronary artery disease
Kasai, T., Miyauchi, K., Yanagisawa, N., Kajimoto, K., Kubota, N., Ogita, M., Tsuboi, S., Amano, A., & Daida, H. (2012) · Heart · doi:10.1136/heartjnl-2012-302689 · Cited by 46
Lipid screening: is it enough to measure total cholesterol concentration?
Neil, H. A. W., Mant, D., Jones, L., Morgan, B., & Mann, J. I. (1990) · BMJ · doi:10.1136/bmj.301.6752.584 · Cited by 47
INTERPRETING MULTIPLE LOGISTIC REGRESSION COEFFICIENTS IN PROSPECTIVE OBSERVATIONAL STUDIES
Abbott, R. D., & Carroll, R. J. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113803 · Cited by 47
Factor VII‐Phospholipid Complex in Male Survivors of Acute Myocardial Infarction
Dalaker, K., Smith, P., Arnesen, H., & Prydz, H. (1987) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1987.tb10646.x · Cited by 47
The Significance of Fish and Fish-oil Enriched Food for Prevention and Therapy of Ischaemic Cardiovascular Disease
Hornstra, G. (1989) · Elsevier eBooks · doi:10.1016/b978-0-12-718051-9.50009-3 · Cited by 47
Serum lipids and apolipoprotein levels in women with acute myocardial infarction.
Johansson, S., Bondjers, G., Fager, G., Wedel, H., Tsipogianni, A., Olofsson, S. ‐., VEDIN, A., Wiklund, O., & Wilhelmsson, C. (1988) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.8.6.742 · Cited by 46
Triglyceride and cardiovascular risk: A critical appraisal
Singh, A. K., & Singh, R. (2016) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.183460 · Cited by 45
Diabetic dyslipidemia
Betteridge, D. J. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90228-3 · Cited by 45
Habitual physical activity and high-density lipoprotein cholesterol in men with primary hypercholesterolemia. The Lipid Research Clinics Coronary Primary Prevention Trial.
Gordon, D. J., Witztum, J. L., Hunninghake, D., Gates, S., & Glueck, C. J. (1983) · Circulation · doi:10.1161/01.cir.67.3.512 · Cited by 45
Restriction fragment length polymorphisms of apolipoprotein B gene in Chinese population with coronary heart disease
Pan, J. P., Chiang, A., Tai, J. J., Wang, S. P., & Chang, M.-S. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.3.424 · Cited by 43
Apoproteins: determinants of lipoprotein metabolism and indices of coronary risk.
Thompson, G. R. (1984) · Heart · doi:10.1136/hrt.51.6.585 · Cited by 44
Current Therapy for Hypercholesterolemia
Blum, C. B. (1989) · JAMA · doi:10.1001/jama.1989.03420240096034 · Cited by 44
Atherosclerosis and apoproteins B and A-I
Kwiterovich, P. O., & Sniderman, A. D. (1983) · Preventive Medicine · doi:10.1016/0091-7435(83)90265-7 · Cited by 44
Alcohol Consumption, Blood Pressure, Lipids, and Cardiovascular Mortality
Criqui, M. H. (1986) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1986.tb05145.x · Cited by 44
Fatty acid composition of the diet: impact on serum lipids and atherosclerosis
Z�llner, N., & Tat�, F. (1992) · Journal of Molecular Medicine · doi:10.1007/bf00180309 · Cited by 44
Ethnic immunity to coronary heart disease?
Vermaak, W. J. H., Ubbink, J. B., Delport, R., Becker, P., Bissbort, S., & Ungerer, J. P. J. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90056-9 · Cited by 43
Relative contribution of triglyceride-rich lipoprotein particle size and number to plasma triglyceride concentration.
Poapst, M. E., Reardon, M., & Steiner, G. A. (1985) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.5.4.381 · Cited by 43
Plasma Triglyceride and Coronary Heart Disease
Austin, M. A. (1992) · Medical science symposia series · doi:10.1007/978-94-011-2700-4_30 · Cited by 43
Non–High-Density Lipoprotein Cholesterol Level as Potential Risk Predictor and Therapy Target
Grundy, S. M. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.11.1379 · Cited by 43
Influence of apolipoprotein H polymorphism on levels of triglycerides
Cassader, M., Ruiu, G., Gambino, R., Guzzon, F., Pagano, A., Veglia, F., Pagni, R., & Pagano, G. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90066-3 · Cited by 41
Triglyceride as a risk factor for ischaemic heart disease in British men: effect of adjusting for measurement error
Egger, M., Smith, G. D., Pfluger, D. H., Altpeter, E., & Elwood, P. C. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00300-1 · Cited by 42
Comparison of two triphasic contraceptives with different progestogens: Effects on metabolism and coagulation proteins
Ball, M. J., Ashwell, E., Jackson, M., & Gillmer, M. D. G. (1990) · Contraception · doi:10.1016/0010-7824(90)90036-u · Cited by 42
Lipid and lipoprotein triglyceride and cholesterol interrelationships: Effects of sex, hormone use, and hyperlipidemia
WAHL, P. W., Walden, C. E., Knopp, R. H., Warnick, G. R., Hoover, J., Hazzard, W. R., & Albers, J. J. (1984) · Metabolism · doi:10.1016/0026-0495(84)90003-9 · Cited by 41
Role ambiguity, Type A behavior, and job satisfaction: Moderating effects on cardiovascular and biochemical responses associated with coronary risk.
Howard, J. H., Cunningham, D. A., & Rechnitzer, P. A. (1986) · Journal of Applied Psychology · doi:10.1037/0021-9010.71.1.95 · Cited by 41
Obesidade na adolescência: fator de risco para complicações clínico-metabólicas
Carneiro, J. R. I., Kuschnir, M. C. C., Clemente, E. L. S., Brandão, M. G., & Gomes, M. B. (2000) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302000000500005 · Cited by 34
Effects of estrogens and progestogens on lipid metabolism
Oster, P., Arab, L., Kohlmeier, M., Mordasini, R., Schellenberg, B., & Schlierf, G. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)32487-5 · Cited by 40
Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels
Leroux, G., Lemieux, I., Lamarche, B., Cantin, B., Dagenais, G. R., Lupien, P. J., & Després, J. (2000) · Metabolism · doi:10.1016/s0026-0495(00)90688-7 · Cited by 39
Serum Lipids, Lipoproteins and Macrovascular Disease in Non‐insulin‐dependent Diabetics: A Possible New Approach to Prevention
Seviour, P. W., Teal, T. K., Richmond, W., & Elkeles, R. S. (1988) · Diabetic Medicine · doi:10.1111/j.1464-5491.1988.tb00965.x · Cited by 39
Effect of dietary fish oil supplementation on peroxidation of serum lipids in patients with non-insulin dependent diabetes mellitus
McGrath, L. T., Brennan, G. M., Donnelly, J. P., Johnston, G. D., Hayes, J. R., & McVeigh, G. E. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05741-2 · Cited by 39
Transdermally administered oestradiol combined with oral medroxyprogesterone acetate: the effects on lipoprotein metabolism in postmenopausal women
Mattsson, L., Samsioe, G., von Schoultz, B., Uvebrant, M., & Wiklund, I. E. (1993) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1993.tb15270.x · Cited by 39
Effect of gemfibrozil on the concentration and composition of serum lipoproteins A controlled study with special reference to initial triglyceride levels
Mänttäri, M., Koskinen, P., Manninen, V., Huttunen, J. K., Frick, M. H., & Nikkilä, E. A. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90054-m · Cited by 39
Dietary Therapy for Non-Insulin-Dependent Diabetes Mellitus
Reaven, G. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809293191310 · Cited by 39
Increased Fibrinolytic Potential after Diet Intervention in Healthy Coronary High‐risk Individuals
Andersen, P. N., Nilsen, D. W. T., BECKMANN, S. L., Holme, I., & Hjermann, I. (1988) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1988.tb17687.x · Cited by 38
Postprandial lipemia and coronary risk
Patsch, W., Esterbauer, H., Föger, B., & Patsch, J. R. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0025-0 · Cited by 36
Effect of Gemfibrozil on lipids, apoproteins, and postheparin lipolytic activities in normolipidemic subjects
Gnasso, A., Lehner, B., Haberbosch, W., Leiss, O., von Bergmann, K., & Augustin, J. (1986) · Metabolism · doi:10.1016/0026-0495(86)90125-3 · Cited by 37
Serum triglyceride and risk of coronary heart disease, stroke, and total mortality in Japanese-American men.
Rhoads, G. G., & Feinleib, M. (1983) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.3.4.316 · Cited by 37
Effects of estrogen dose and smoking on lipid and lipoprotein levels in postmenopausal women
Krauss, R. M., Perlman, J. A., Ray, R., & Petitti, D. B. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(88)90198-6 · Cited by 36
9 Hypertriglyceridaemia, triglyceride-rich lipoproteins and coronary heart disease
Hamsten, A. (1990) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80084-9 · Cited by 36
Increased plasma and aortic triglycerides in rabbits after acute administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin
Lovati, M. R. (1984) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(84)90079-6 · Cited by 35
Effect of long-term hormonal contraception on plasma lipids
Deslypère, J. P., Thiéry, M., & Vermeulen, A. (1985) · Contraception · doi:10.1016/0010-7824(85)90063-0 · Cited by 35
Serum lipoprotein effects of conjugated estrogen and a sequential conjugated estrogen-medrogestone regimen in hysterectomized postmenopausal women
Sonnendecker, E. W. W., Polakow, E. S., Benadé, A. J. S., & Simchowitz, E. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90174-9 · Cited by 35
Coronary Heart Disease Risk Associated with Primary Isolated Hypertriglyceridemia; a Population‐Based Study
Saadatagah, S., Pasha, A. K., Alhalabi, L., Sandhyavenu, H., Farwati, M., Smith, C. Y., Wood‐Wentz, C. M., Bailey, K. R., & Kullo, I. J. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019343 · Cited by 35
Effect of Dietary Fish Oil on Hyperlipidaemia due to Isotretinoin and Etretinate
Marsden, J. R. (1987) · Human Toxicology · doi:10.1177/096032718700600308 · Cited by 34
Life Style and Cardiovascular Risk Factors in the Japanese Population-From an Epidemiological Survey on Serum Lipid Levels in Japan 1990. Part 1: Influence of Life Style and Excess Body Weight on HDL-Cholesterol and Other Lipid Parameters in Men
Yamamoto, A., Temba, H., Horibe, H., Mabuchi, H., Saitō, Y., Matsuzawa, Y., Kita, T., & Nakamura, H. (2003) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10.165 · Cited by 34
The fibrates in clinical practice: Focus on micronised fenofibrate
Shepherd, J. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)05380-2 · Cited by 34
Long-term effects of Org OD 14 on lipid metabolism in post-menopausal women
Kloosterboer, H. J., Benedek-Jaszmann, L. J., & Kicovic, P. M. (1990) · Maturitas · doi:10.1016/0378-5122(90)90058-e · Cited by 34
Influence of apo E phenotype on postprandial triglyceride and glucose responses in subjects with and without coronary heart disease
Dart, A. M. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06062-5 · Cited by 34
A prospective survey of risk factors in young adults with arterial occlusive disease
Aronson, D. C., Ruys, T. A., van Bockel, J. H., Briët, E., Brommer, E. J. P., Leuven, J. A. G., Kempen, H. J. M., Feuth, J. D. M., & Giesberts, M. A. H. (1989) · European Journal of Vascular Surgery · doi:10.1016/s0950-821x(89)80087-8 · Cited by 34
Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia
Bruckert, É., Gennes, J. L. D., Malbecq, W., & Baigts, F. (1995) · Clinical Cardiology · doi:10.1002/clc.4960181107 · Cited by 33
Hypertriglyceridemia and the fibrate trials
Færgeman, O. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200012000-00007 · Cited by 33
Patients with combined hypercholesterolemia-hypertriglyceridemia show an increased monocyte-endothelial cell adhesion in vitro: Triglyceride level as a major determinant
de Gruijter, M., Hoogerbrugge, N., van Rijn, M. A., Koster, J. F., Sluiter, W. J., & Jongkind, J. F. (1991) · Metabolism · doi:10.1016/0026-0495(91)90203-9 · Cited by 33
Multivariate analysis. Some guidelines for physicians
Lew, R. A. (1983) · JAMA · doi:10.1001/jama.249.5.641 · Cited by 33
Comparison of the efficacy and tolerability of simvastatin and atorvastatin in the treatment of hypercholesterolemia
Recto, C. S., Acosta, S., & Dobs, A. S. (2000) · Clinical Cardiology · doi:10.1002/clc.4960230910 · Cited by 33
Insulin Resistance, Compensatory Hyperinsulinemia, and Coronary Heart Disease: Syndrome X Revisited
Reaven, G. M. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070238 · Cited by 32
Contraceptives containing desogestrel or levonorgestrel have different effects on serum lipoproteins and post‐heparin plasma lipase activities
Kaupplnen‐Makelln, R., Kuusl, T., Ylikorkala, O., & Tlkkanen, M. J. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb00959.x · Cited by 32
Estrogenic effect of gestodene- or desogestrel-containing oral contraceptives on lipoprotein metabolism
Leuven, J. A. G., Dersjant-Roorda, M. C., Helmerhorst, F. M., de Boer, R., Neymeyer-Leloux, A., & Havekes, L. M. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)90582-r · Cited by 32
The Tromsø Heart Study: serum selenium and risk of myocardial infarction a nested case-control study.
Ringstad, J., Jacobsen, B. K., Thomassen, Y., & Thelle, D. S. (1987) · Journal of Epidemiology & Community Health · doi:10.1136/jech.41.4.329 · Cited by 32
The Genesis of Atherosclerosis in Pediatric Age-Group
Haust, M. D. (1990) · Pediatric Pathology · doi:10.3109/15513819009067112 · Cited by 32
Premature death and associated risk factors in urban middle-aged men
Petersson, B., Trell, E., & HOOD, B. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90096-2 · Cited by 33
Black/white differences in risk factors for arteriographically documented coronary artery disease in men
Freedman, D. S., Gruchow, H. W., Manley, J. C., Anderson, A. J., Sobocinski, K. A., & Barboriak, J. J. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90214-7 · Cited by 32
Single‐center retrospective study of long‐term use of low‐dose acitretin (Soriatane®) for psoriasis
Lee, E., & Koo, J. Y. M. (2004) · Journal of Dermatological Treatment · doi:10.1080/095466303100184473 · Cited by 31
Plasma lipids and lipoproteins in Japanese male patients with coronary artery disease and in their relatives
Kukita, H., Imamura, Y., Hamada, M., Joh, T., & Kokubu, T. (1982) · Atherosclerosis · doi:10.1016/0021-9150(82)90122-8 · Cited by 31
Diabetic dyslipidaemia
Durrington, P. N. (1999) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.1999.0019 · Cited by 31
Treatment of common lipoprotein disorders.
Brown, W., Goldberg, I. J., & Ginsberg, H. N. (1984) · Progress in cardiovascular diseases · doi:10.1016/0033-0620(84)90017-3 · Cited by 30
The importance of dyslipidaemia in the pathogenesis of cardiovascular disease in people with diabetes
Gonna, H., & Ray, K. K. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13691 · Cited by 30
Influence of serum triglycerides on the HDL pattern in normal subjects and patients with coronary artery disease
Calabresi, L., Franceschini, G., Sirtori, M., GIANFRANCESCHI, G., Werba, J. P., & SIRTORI, C. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90006-5 · Cited by 30
VLDL compositional changes and plasma levels of triglycerides and high density lipoprotein
Brites, F. D., Bonavita, C. D., Cloës, M., Yael, M. J., Fruchart, J., Castro, G. R., & Wikinski, R. L. W. (1998) · Clinica Chimica Acta · doi:10.1016/s0009-8981(97)00193-9 · Cited by 30
Pharmacotherapy of Diabetes: New Developments
Mogensen, C. E. (2007) · Springer eBooks · doi:10.1007/978-0-387-69737-6 · Cited by 30
Metabolic effects of three new low-dose pills: A six-month experience
Miccoli, R., Mc, O., Fruzzetti, F., Giampietro, O., Melis, G. B., Ricci, C., Bertolotto, A., FIORETTI, P., & Navalesi, R. (1989) · Contraception · doi:10.1016/0010-7824(89)90039-5 · Cited by 30
Highly active antiretroviral therapy and coronary heart disease: the need for perspective
Egger, M., Junghans, C., Friis‐Møller, N., & Lundgren, J. D. (2001) · AIDS · doi:10.1097/00002030-200100005-00023 · Cited by 30
Metabolic syndrome: A review of emerging markers and management
Singh, B. K., Arora, S., Goswami, B., & Mallika, V. (2009) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2009.04.012 · Cited by 29
Beneficial effects of fish-oil supplements on lipids, lipoproteins, and lipoprotein lipase in patients with glycogen storage disease type l
Levy, E. H., Thibault, L., Turgeon, J. P., ROY, C. C., Gurbindo, C., Lepage, G., Godard, M., Rivard, G., & Seidman, E. G. (1993) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/57.6.922 · Cited by 29
High-Density Lipoprotein Cholesterol, Plasma Triglyceride, and Coronary Heart Disease: Pathophysiology and Management
Patsch, W., & Gotto, A. M. (1995) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61018-2 · Cited by 29
What Causes Premature Coronary Artery Disease?
Le, A., Peng, H., Golinsky, D., Scipio, M. D., Lali, R., & Paré, G. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01200-y · Cited by 33
Small LDL and Its Clinical Importance as a New CAD Risk Factor: A Female Case Study
Superko, H. R., Nejedly, M., & Garrett, B. C. (2002) · Progress in Cardiovascular Nursing · doi:10.1111/j.0889-7204.2002.01453.x · Cited by 28
8 Effects of sex steroids on serum lipids and lipoproteins
Jensen, J. (1991) · Baillière s Clinical Obstetrics and Gynaecology · doi:10.1016/s0950-3552(05)80294-9 · Cited by 28
The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women
Bayrak, A., Aldemir, D., Bayrak, T., Çorakçı, A., & Dursun, P. (2006) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-006-0187-2 · Cited by 29

Authors: Hulley, S. B., Rosenman, R. H., Bawol, R. D., & Brand, R. J.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1980-06-19
Volume: 302
Issue: 25
Pages: 1383-1389
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm198006193022503
OpenAlex: W1989258056
Cited by: 702
References: 88
Citations by year: 2025: 4 · 2024: 1 · 2023: 3 · 2022: 2 · 2021: 7 · 2020: 4 · 2019: 5 · 2018: 5 · 2017: 4 · 2016: 7 · 2015: 9 · 2014: 8 · 2013: 7 · 2012: 11
FWCI: 53.22
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
DigitalGeorgetown (Georgetown University Library) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Keywords: triglycerides, coronary artery disease, hypertriglyceridemia, causal inference, cholesterol, preventive medicine, burden of proof, screening, lipid-lowering therapy, clinical decision-making
MeSH terms: Adult, Cholesterol, Coronary Disease, Decision Making, Epidemiologic Methods, Ethics, Medical, Health Policy, Humans, Middle Aged, Retrospective Studies, Risk, Triglycerides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Epidemiology as a Guide to Clinical Decisions: The Association between Triglyceride and Coronary Heart Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks